New study shows that AI can predict lung cancer from digitized patient tissue samples rapidly and with a high degree of ...

Researchers have unveiled a potential paradigm shift in treatment strategies that could significantly improve patients' ...

Researchers at Saint Louis University School of Medicine investigated differences in T-cell responses between male and female patients with lung cancer that may help direct future treatments.

A triple-whammy of advanced new diagnostic and treatment options holds the promise for better outcomes for New Jersey lung ...

A collaboration of doctors from Cedars-Sinai Medical Center in Los Angeles and Brigham and Women’s Hospital in Boston, looked ...

While none of the experimental combinations met efficacy targets, durvalumab with monalizumab and ceralasertib showed ...

Pfizer is trying to increase doctor awareness of and testing for a rare lung cancer mutation to help boost use of its drug ...

Lung cancer screening experts from around the globe delivered strategies and best practices for improving access to screening ...

Keytruda's dominance as a mainstay in cancer immunotherapy isn’t threatened by an experimental Chinese drug, a top Merck ...

Hetronifly in combination with chemotherapy was shown to improve survival of patients with extensive stage small cell lung ...

The HER2-specific tyrosine kinase inhibitor zongertinib was well tolerated and demonstrated promising efficacy in patients ...

A new study published in the science journal Cell Reports Medicine demonstrates how AI can predict lung cancer from digitized patient tissue samples rapidly and with a high degree of accuracy.